Skip to main content

Insights

Cancer June 15, 2022

Researchers discuss health disparities in melanoma diagnoses

By Krista Conger

While melanoma rates have leveled off for most of the United States, Black and Latino communities are at a higher risk for the disease.

It's that time of the year. With temperatures rising and outdoor graduation season in full swing, it's more important than ever to be mindful of the risks of sun exposure.

But a recent JAMA Oncology study by Stanford Medicine dermatologist and professor Eleni Linos, MD, DrPH, medical student Michael Chen and their colleagues, delivered some good news on the skin cancer front: The yearly incidence of melanoma — the fifth most common cancer in the United States, and the most deadly type of skin cancer — has plateaued for the first time since the 1930s.

The seemingly good news, however, hides a troubling disparity. Linos and Chen found that Black and Latino people are more likely to be diagnosed with a more advanced form of the disease, compared to white people. So what's going on? Are clinicians less likely to screen certain populations for skin cancers? Are some groups less aware of the consequences of sun exposure or the warning signs that should prompt a visit to the doctor?

I spoke with Linos and Chen to learn more about this issue.

Can you describe what prompted your study and what you learned?

Linos: Melanoma is a serious skin cancer. We wanted to understand how rates of melanoma have changed over the past decade and to understand what patient groups are most affected. We analyzed data from nearly 200,000 people diagnosed with melanoma from 2010 to 2018 in the United States and looked for correlations among their sex, race, ethnicity and other socioeconomic factors with the thickness of their tumors. This is important because tumor thickness determines how dangerous a melanoma is. The thicker the melanoma, the more likely it is to spread and potentially be lethal.

We were surprised to find that the overall incidence of melanoma had stabilized. This hasn't happened in more than 70 years in the United States. But the incidence of thick melanomas continued to increase. Unfortunately, this disproportionally affects minority communities: about 21% of Black patients, and 11% of Latino patients were diagnosed with the thickest melanomas, compared to about 6% of non-Latino white patients. Also, about 10% of people of lower socioeconomic status of any race were diagnosed with the thickest tumors, compared to about 5% with higher levels of education and income.

Why is this happening?

Chen: Our study raises concerns about disparities in melanoma awareness and access to dermatologists in Black and Latino communities. This is especially concerning given that we found, despite the plateau we observed in overall melanoma rates, the thickest tumors continue to increase in incidence. Black patients, Latino patients, and patients with lower incomes and educational levels bear a disproportionate burden of deadly melanoma.

One issue is that Black communities are often neglected in melanoma public health campaigns. This can give the false impression that there is no skin cancer risk for Black patients. We believe that public health campaigns need to focus on all populations, including those with a higher risk of more severe disease.

What other interventions can be done?

Linos: Primary prevention of melanoma is really important. For example, tanning beds are known to cause melanoma, but are still being used by too many people. This needs to stop. Our national social media-based public health campaign to reduce the use of tanning beds, funded by the National Cancer Institute, focused specifically on young women and men who use indoor tanning beds and reached 10 million people in April 2022.

Chen: Physician and patient awareness are both important, and there are many initiatives focused on increasing awareness, such as Wipe Out Melanoma — California. There are also many emerging technologies that may be able to facilitate care for those with reduced health care access, such as teledermatology.

Linos: Our team is also working on a public health campaign focused on Black communities to increase awareness about melanoma. So far we have conducted interviews with people across the country to understand some of the barriers and how to address them. A team of artists, Isabella de Vere Hunt, MD, Jenna Lester, MD, and I have worked with a video production company and the Melanoma Research Alliance to create a video to better inform Black people about the potential risk of melanoma in an educational and helpful way. The melanoma information is tailored for Black people, informed by in-depth interviews regarding melanoma awareness in Black communities.

Photo courtesy of Eleni Linos

About Stanford Medicine

Stanford Medicine is an integrated academic health system comprising the Stanford School of Medicine and adult and pediatric health care delivery systems. Together, they harness the full potential of biomedicine through collaborative research, education and clinical care for patients. For more information, please visit med.stanford.edu.

Krista-Conger

Science writer

Krista Conger

Senior science writer Krista Conger, PhD ’99, covers cancer, stem cells, dermatology, developmental biology, endocrinology, pathology, hematology, radiation oncology and LGBTQ+ issues for the office. She received her undergraduate degree in biochemistry at the University of California, Berkeley and her PhD in cancer biology from Stanford University. After completing the science writing program at UC Santa Cruz, she joined the Stanford Medicine Office of Communications in 2000. She enjoys distilling complicated scientific topics into engaging prose accessible to the layperson. Over the years, she has had chronicled nascent scientific discoveries from their inception to Food and Drug Administration approval and routine clinical use — documenting the wonder and long arc of medical research. Her writing has repeatedly been recognized with awards from the Counsel for the Advancement and Support of Education and the Association of American Medical Colleges. She is a member of the National Academy of Science Writers and a certified science editor through the Board of Editors in the Life Sciences. In her spare time, she enjoys textile arts, experimenting with new recipes and hiking in beautiful northwestern Montana, where she was raised and now lives.